Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1 1

Status

Completed 5Recruiting 3Unknown 2Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5

Conditions

Breast Neoplasms 37Carcinoma, Non-Small-Cell Lung 28Glioblastoma 24Brain Neoplasms 23Esophageal Neoplasms 20Rectal Neoplasms 19Stomach Neoplasms 17Glioma 17Lung Neoplasms 16Colorectal Neoplasms 16Astrocytoma 14Pancreatic Neoplasms 12Central Nervous System Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Neoplasm Metastasis 10Head and Neck Neoplasms 10Gliosarcoma 10Sarcoma 9Oligodendroglioma 9Recurrence 8Neoplasms 8Adenocarcinoma Of Esophagus 8Esophageal Squamous Cell Carcinoma 7Uterine Cervical Neoplasms 6Ovarian Neoplasms 6Colonic Neoplasms 6Pilonidal Sinus 5Melanoma 5Carcinoma, Ovarian Epithelial 5Adenocarcinoma of Lung 5

Interventions

Ipilimumab 114pembrolizumab 94Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Melanoma × Surgical Procedures, Operative × Clear all
NCT01005745 2025-12-19

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
19 enrolled 7 charts
Dermatologic

Melanoma

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed
50 enrolled
Dermatologic

Melanoma, Recurrence

NCT01760499 2017-04-19

Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
15 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

NCT00004022 2013-04-05

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
Dermatologic

Melanoma

NCT00002860 2012-01-13

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

SWOG Cancer Research Network

Phase 2 Completed
77 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡